![Logo for Tyme Technologies Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fc5888-2023-03-20-01-43-47.png&w=256&q=100)
Tyme Investor Relations Material
Latest events
![Logo for Tyme Technologies Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fc5888-2023-03-20-01-43-47.png&w=128&q=100)
Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) for patients with a broad range of cancers. The company is developing THOR, a synthetic retinoid prodrug designed to be an orally active anticancer agent in the treatment of cancers. It offers Thymidylate synthase (TYMS) inhibitors and other chemicals used in research. The company has clinical stage product candidates under clinical development and preclinical stage programs under nonclinical development.
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
TYME
Country
đșđž United States